- This group of themes is centred on trends that consider health access and equality within developing countries and the delivery of remote health-care solutions, both of which aim to make health care more accessible and affordable for all. New innovations in genetics and devices and medicines will also serve to improve patient outcomes and provide superior economic value.
-
Health equity
- There are opportunities in companies linked to growing access to health care for those in emerging markets and for patients with rare diseases, as well as increasing ‘health equity’ within populations.
-
-
Connected health
- Technology is being developed to deliver remote health-care services digitally which can provide better, more accessible and more affordable care for all.
-
-
Genetic technologies
- A wide range of technologies are driving life-sciences development – not only genes, but also proteins, metabolites and the microbiome. Companies linked to this theme are not just in the biotechnology sector, but include medical tools and diagnostics companies.
-
Your capital may be at risk. The value of investments and the income from them can fall as well as rise and investors may not get back the original amount invested.
These opinions should not be construed as investment or other advice and are subject to change. This material is for information purposes only. Any reference to a specific security, country or sector should not be construed as a recommendation to buy or sell investments in those countries or sectors. Please note that holdings and positioning are subject to change without notice.
